Clinical experience and safety of Janus kinase inhibitors in giant cell arteritis: a retrospective case series from Sweden

The Janus kinase (JAK)–STAT signaling pathway is relevant in both Takayasu and giant cell arteritis (GCA), and the use of JAK inhibitors (JAKi) in arthritis, psoriasis, and inflammatory bowel disease is nowadays common. Some evidence of the clinical efficacy of JAKi in GCA exists and a phase III ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Per, Skoglund, Oliver, Hemgren, Cecilia, Sjöwall, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247956/
https://www.ncbi.nlm.nih.gov/pubmed/37304255
http://dx.doi.org/10.3389/fimmu.2023.1187584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247956/
https://www.ncbi.nlm.nih.gov/pubmed/37304255
http://dx.doi.org/10.3389/fimmu.2023.1187584

Ejemplares similares